Sivakolundu, Dinesh K. http://orcid.org/0000-0003-4539-0981
West, Kathryn L. http://orcid.org/0000-0003-3059-8923
Zuppichini, Mark D. http://orcid.org/0000-0003-0856-6116
Wilson, Andrew http://orcid.org/0000-0002-1010-858X
Moog, Tatum M. http://orcid.org/0000-0002-1407-8621
Blinn, Aiden P.
Newton, Braeden D. http://orcid.org/0000-0001-5668-8623
Wang, Yeqi http://orcid.org/0000-0003-1072-8479
Stanley, Thomas
Guo, Xiaohu http://orcid.org/0000-0002-7610-6923
Rypma, Bart http://orcid.org/0000-0001-9727-9543
Okuda, Darin T. http://orcid.org/0000-0002-6499-1523
Funding for this research was provided by:
National Multiple Sclerosis Society Research Grant (RG-1507-04951)
Article History
Received: 5 February 2020
Revised: 12 May 2020
Accepted: 14 May 2020
First Online: 28 May 2020
Compliance with ethical standards
:
: KW, MZ, AW, XG, TM, AB, YW, TS, and BR report no disclosures. DO received advisory and consulting fees from Celgene, EMD Serono, Genentech, Genzyme, and Novartis and research support from Biogen. DS, BN, and DO have a patent pending related to the submitted work.
: This study was approved by the University of Texas Southwestern Medical Center Institution Review Board. Written informed consent was obtained from all participants prior to study participation.